McMinn Rachel
Neurogene Inc. · Chief Executive Officer
McMinn Rachel is listed in public filings as director, officer: Chief Executive Officer. This McMinn Rachel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neurogene Inc. (NGNE). Investors use McMinn Rachel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $30M1.3M shares | SellMar 26, 2026 | $74.0K3.4k shares | $22.07 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.7M155.1k shares | Grant / ExerciseFeb 20, 2026 | $2.7M155.1k shares | $17.64 | -- | |
| --1.3M shares | Grant / ExerciseFeb 20, 2026 | Disclosure amount unavailable25.9k shares | -- | -- | |
| $2.3M143.5k shares | Grant / ExerciseMar 26, 2025 | $2.3M143.5k shares | $16.14 | -- | |
| --1.3M shares | Grant / ExerciseMar 26, 2025 | Disclosure amount unavailable23.9k shares | -- | -- | |
| $26M1.3M shares | BuyNov 22, 2024 | $969.0K47.5k shares | $20.40 | -- |